Grynberg M, Raad J, Comtet M, et al. Future Oncol. 2018;14(5):483-490.
Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72:1117-1130.
Rzepka-Gorska I, Tarnowski B, Chudecka-Głaz A, et al. Premature menopause in patients with BRCA1 gene mutation. Breast Cancer Res Treat. 2006;100:59-63.
Johnson L, Sammel MD, Domchek S, et al. Anti-Mullerian hormone levels are lower in BRCA2 mutation carriers. Fertil. Steril. 107(5):1256-1265.
Wang ET, Pisarska MD, Bresee C, et al. BRCA1 germline mutations may be associated with reduced ovarian reserve. Fertil Steril. 2014;102(6):1723-1728.